Concepedia

A phase II study of combination therapy with 5′-deoxy-5-fluorouridine and cisplatin in the treatment of advanced gastric cancer with primary foci

Wasaburo Koizumi, Minoru Kurihara, T Sasai, Shigeaki Yoshida, Kimitomo Morise, Akimichi Imamura, S Akazawa, Takashi Betsuyaku, Shunji Ohkubo, Hiroshi Takahashi,

Cancer · 1993 · 45 citations · 23 references

DOI

Abstract

Combined therapy with 5'-DFUR and CDDP is a safe and effective treatment regimen for advanced gastric cancers with primary foci which stresses the patient's quality of life, especially when used in an outpatient setting.

References

23

cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.

Schabel Fm, Trader Mw, Laster Wr et al. · PubMed · 1980 · 433 citations

, , +17

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Kevin J. Scanlon, Edward M. Newman, Yuzhi Lu et al. · Proceedings of the National Academy of Sciences · 1986 · 369 citations

, , +16

Phase II study with the combination etoposide, doxorubicin, and cisplatin in advanced measurable gastric cancer.

P. Preusser, H. Wilke, W. Achterrath et al. · Journal of Clinical Oncology · 1989 · 302 citations

, , +14

Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.

Hideo Ishitsuka, Masanori Miwa, Kenji Takemoto et al. · PubMed · 1980 · 139 citations

, , +14

Fluorinated pyrimidine nucleosides. 3. Synthesis and antitumor activity of a series of 5'-deoxy-5-fluoropyrimidine nucleosides

Alan F. Cook, Michael J. Holman, M. J. KRAMER et al. · Journal of Medicinal Chemistry · 1979 · 137 citations

, , +18